ENTRY IN THE ADHD DRUGS MARKET: WELFARE IMPACT OF GENERICS AND ME-TOO'S*

Recent decades have seen a growth in treatments for attention deficit hyperactivity disorder (ADHD) including many branded and generic drugs. In the early 2000's, new drug entry dramatically altered market shares. We estimate a demand system for ADHD drugs and assess the welfare impact of new d...

Descripción completa

Detalles Bibliográficos
Autores principales: Bokhari, Farasat A S, Fournier, Gary M
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons Ltd 2013
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4373170/
https://www.ncbi.nlm.nih.gov/pubmed/25821242
http://dx.doi.org/10.1111/joie.12017

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4373170/
https://www.ncbi.nlm.nih.gov/pubmed/25821242
http://dx.doi.org/10.1111/joie.12017

Ejemplares similares